Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

First Person C-level IT executives share their strategic insights and expertise on making critical, real-world decisions that will shape the future of their companies. This blog is part of the Foundry ...